Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pharma’s trillion-dollar opportunity: Investing in women’s health
Women’s health remains chronically underfunded, yet closing the gap could unlock huge value for women and the global economy.
Read more
The road to representative trial recruitment
Achieving equal and accurate representation in clinical trials has long been a challenge for the pharmaceutical industry. We have made great progress towards the goal of patient inclusivity, but what more can be done to ensure that all patient groups are adequately represented and how can digital help to achieve this?
Pfizer's Mace Rothenberg on his passion for advancing oncology
Mace Rothenberg, Chief Medical Officer, Pfizer, speaks to us about his sustained passion for advancing the field of oncology, the importance of diverse representation in patient groups, and the challenges of balancing lifespan with health span.
Is pharma recession-proof?
How ‘recession-proof’ is pharma, and what challenges has COVID-19 posed to this famously robust industry?
The fight against the superbugs
How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?
Picking the perfect campaign star
Celebrity endorsements can transform a mediocre pharma campaign into a pitch-perfect hit, but choosing the right spokesperson is crucial. We explore the practice of attaching famous faces to campaigns and how to ensure a representative strikes the right chord
Drugs: it does exactly what it says on the label
Labelling is the vessel through which vital instructions and information about products are communicated to end-users, and in the pharmaceutical industry, medical affairs are entrusted with safeguarding these products from misuse, by balancing scientific accuracy with conciseness and coherence.
Launching the Future of Technology in 3...2...1...
Innovative technology has changed the game in pharma, from AI-powered marketing campaigns to DNA sequencing tools. When this technology is combined with creative thinking, the potential for success is vast. It is critical for pharma to marry creativity with technology as they drive towards a patient-centric future
Almirall’s Francesca Wuttke on the value of digital innovation for patients
Francesca Wuttke, Chief Digital Officer, Almirall, shares her thoughts on how digital transformation, motivation and innovation can change patients’ lives for the better.
Loading posts...
« Previous
1
…
25
26
27
28
29
…
32
Next »